Qualified guidance.
Individual context.
A more considered approach.
Peptides are an increasingly discussed area of performance, health and longevity. Understanding a peptide requires more than knowing its name. Context, evidence, individual circumstances and appropriate professional oversight matter.
Bolko Aleksiev
Performance & Longevity Coach · Certified Peptide TherapistBolko leads Nabō's performance strategy, human optimisation and peptide education. His work brings peptide research into the wider context of performance, recovery, longevity, lifestyle, training and health optimisation.
His path began in Los Angeles as a personal trainer, then in London as a professional sports performance coach with Premier League footballers, before he qualified as a High-Performance Coach working with executives, professional athletes and individuals navigating performance and mindset setbacks, including four years as a Wellness Ally for One&Only Resorts.
That nearly three-decade arc, pairing physical training with behaviour and mindset work, shapes how he approaches peptide education here: as one consideration within a much wider strategy, never as a starting point in itself. Every conversation begins with the individual's goals and history, not with a peptide name.
Education: BSc in Sports Science. Certification: Certified Peptide Therapist through SSRP Institute.
Short chains of amino acids, with a wide research landscape.
Peptides are short chains of amino acids that can act as signalling molecules within biological systems. Different peptides are being researched across a wide range of pathways and applications, and the research landscape is broad and continually developing.
Four principles, before any peptide is discussed.
Evidence Before Enthusiasm
We start from human clinical data, not short-term transformation stories or anecdotal reports.
Adjunct, Not Foundation
Peptide considerations sit alongside training, nutrition, sleep and recovery. They never replace them.
Individual, Not Templated
What's relevant depends on your own bloodwork, history and goals, never a generic protocol applied to everyone.
Appropriate Referral, Always
Clinical assessment, diagnosis and prescribing stay with appropriately licensed healthcare professionals.
Six areas, in context.
Recovery
Research involving tissue repair and recovery pathways.
Metabolic Health
Research involving metabolic signalling and body composition.
Performance
Research involving physical performance and adaptation.
Cognitive Health
Research involving neurological and cognitive pathways.
Healthy Ageing
Research involving biological signalling associated with ageing and resilience.
Skin & Tissue
Research involving skin and tissue pathways.
Named for illustration, not as a menu.
These come up most often in conversation, mapped to the areas above. None of this is a recommendation or a protocol: what's actually relevant to you depends on your own bloodwork and history, worked out through Signa Peptide's structured intake, not a list on a website.
BPC-157 & TB-500
The two compounds most frequently discussed in the context of soft-tissue and joint recovery research.
5-Amino-1MQ & GLP-1 Class
Researched for body composition and metabolic signalling, considered alongside, never instead of, nutrition and training.
MOTS-c
A newer, still-developing area of research interest in cellular energy production.
Ipamorelin
Considered only within the risk principles below, never pursued for chronic elevation.
Selective Use
A more targeted, case-by-case area, considered on individual merit rather than as a default.
More isn't the goal. Clarity is.
Function, Not Just Symptom
Every consideration starts with whether it addresses an underlying system, not just a visible effect.
Cycled, Never Chronic
Where growth hormone modulation is relevant, it's approached with minimal effective dosing and a planned exit, not indefinite use.
Checked Against the Full Picture
A new consideration is weighed against everything already part of your protocol and history, not added in isolation.
More Isn't the Goal
Stacking multiple considerations without biomarker feedback usually makes it harder to tell what's working, not easier.
Six steps, always ending with appropriate referral.
Understand
Understand the objective.
Review
Review available information and context.
Educate
Explain research, limitations and uncertainties.
Structure
Discuss how peptide considerations may fit within a wider strategy.
Monitor
Consider appropriate monitoring and reassessment.
Refer
Involve an appropriately licensed healthcare professional where clinical assessment, diagnosis or prescribing is required.
A focused, education-led conversation.
Exploring whether peptide therapy is relevant to your individual circumstances. Delivered through Signa Peptide, Nabō's independent peptide platform, separate from the Nabō Wellness practice.
Book a Consultation ↗A comprehensive blood test is required before your consultation. Full requirements are listed on the booking page.
Training. Nutrition. Sleep. Recovery. Behaviour. Health. These remain the foundations. Where peptide therapy is relevant, it should sit within a broader strategy rather than become the strategy.
An independent platform, built for a market that needed more structure.
Signa Peptide is Nabō's sister platform for peptide products: a separate, independent site, distinct from the Nabō practice itself. Every protocol there starts from a structured intake and bloodwork, not a generic template, and is reviewed by Signa's own practitioner team before anything is dispensed.
The peptide market today tends to sit at two extremes. On one side, anonymous suppliers offering a vial, a syringe and a dosing chart, with concentration varying batch to batch and reconstitution left entirely to the buyer. On the other, clinical settings that can feel overmedicalised or inaccessible for people who simply want clarity. Signa Peptide was founded to sit between the two: structured and transparent, without positioning peptides as a shortcut, and without the friction of a traditional clinic. Signa is careful to draw a boundary around what it is: an education and coaching resource, not a pharmacy dispensing prescriptions, the same distinction Nabō draws about its own scope.
In practice, that shows up as independent third-party testing on every batch, with documentation available for what's dispensed, and a practitioner who can amend or decline a protocol that doesn't fit someone's file, pointing them to their own physician rather than a workaround. Relevant markers are reviewed on a regular cycle, so a protocol is something that gets reassessed, not something fixed at the outset.
Nabō and Signa Peptide are related in ethos but operate as separate platforms. Product details, sourcing and protocols live on Signa Peptide, not here.
Visit Signa Peptide ↗Common questions.
Does Nabō prescribe peptides?+
No. Nabō is a coaching and education practice, not a medical clinic. Where peptide therapy is relevant, we refer to Signa Peptide's practitioner team or to a licensed physician.
Why is bloodwork required before a consultation?+
Because a peptide conversation without data is just a guess. A comprehensive blood test gives the consultation something real to reason from, rather than a generic recommendation.
How is this different from buying peptides online?+
Anonymous suppliers sell a vial and a dosing chart with no structure behind it. Signa Peptide starts every protocol from an intake and bloodwork, reviews it against a practitioner's judgement, and reassesses it on a regular cycle rather than leaving it fixed.
Will this replace my training and nutrition plan?+
No. Training, nutrition, sleep and recovery remain the foundation. Where peptide therapy is relevant, it sits within that strategy, never in place of it.
What happens after the consultation?+
If a peptide consideration is relevant, Signa Peptide designs and sources it from there. If it isn't, or something closer to clinical care is called for, you're referred to the right person. Either way, you leave with clarity, not a sales pitch.